Omnicell To Discuss Aesynt Acquisition At The 27th Annual Piper Jaffray Health Care Conference
Details of the acquisition will be discussed at the conference and are also included in an investor presentation found in the investor relations section of our website. The investor presentation can also be accessed by clicking here.
Availability: The audio-webcast of the live presentation may be accessed by visiting:
Following the conference, a replay of the audio-webcast will be archived for 30 days on the
More than 3,200 customers worldwide have utilized Omnicell Automation and Analytics solutions to increase operational efficiency, reduce errors, deliver actionable intelligence and improve patient safety. Omnicell Medication Adherence solutions, including its MTS Medication Technologies brand, provide innovative medication adherence packaging solutions to help reduce costly hospital readmissions. In addition, these solutions enable approximately 7,000 institutional and retail pharmacies worldwide to maintain high accuracy and quality standards in medication dispensing and administration while optimizing productivity and controlling costs.
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/omnicell-to-discuss-aesynt-acquisition-at-the-27th-annual-piper-jaffray-health-care-conference-300183843.html
News Provided by Acquire Media